Monte Rosa Therapeutics (GLUE) Earnings Date & Reports
A.I. Advisor
published Earnings
GLUE is expected to report earnings to rise 9.30% to -46 cents per share on November 07
Q3'24
Est.
$-0.47
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.06
Q4'23
Missed
by $0.19
Q3'23
Beat
by $0.02
The last earnings report on August 08 showed earnings per share of -43 cents, beating the estimate of -52 cents. With 191.81K shares outstanding, the current market capitalization sits at 317.30M.